entertainment -WSS

entertainment

author：explore 2025-09-27 12:55:18 - browse：1

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Dozens dead from Maui wildfires: What we know about the victims

WSS

Indictment alleges Trump's ex

Idaho college killings prosecutors challenge defense's grand jury claims

FDA warns medical device makers about rise in fabricated data

Flagship Pioneering startup Sonata Therapeutics lays off 21

Secretariat’s lessons for human medicine

After Optum profits sink, UnitedHealth makes changes

focus

entertainment

Wikipedia

Tori Bowie and the unacceptable rates of Black maternal death

Indictment alleges Trump's ex

FDA approval of Sarepta Duchenne genetic therapy gives me hope

As AI regulations shape up, health tech startups beg for clarity

Cancer drug shortages should be causing more outrage

Health AI: on the border between health care and tech

Activists slam private health insurers over coverage restrictions

A new drug could help frostbite victims avoid its ravages

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

In 'major milestone,' FDA approves first cell therapy for solid tumors

hotspot

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Indictment alleges Trump's ex

Indictment alleges Trump's ex

YouTube cracks down on misinformation on cancer treatment

Hospitals are dialing back on venture capital investing

Indictment alleges Trump's ex

hotspot

explore

focus

focus